TAF9A Antibodies

Santa Cruz Biotechnology delivers a wide array of TAF9A monoclonal antibodies for investigating TAF9A's role in various biological processes. TAF9A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAF9A, or TATA-binding protein-associated factor 9A, is a crucial component of the transcriptional machinery, playing a significant role in the regulation of gene expression. TAF9A participates in the assembly of the transcription factor complex and enables the transcription of numerous genes, influencing cellular processes such as differentiation and proliferation. Research has shown that TAF9A activity impacts various diseases, including cancer development and progression. Scientists can utilize TAF9A monoclonal antibodies to explore gene regulation mechanisms and cellular signaling pathways. Advanced research with TAF9A monoclonal antibodies helps reveal new therapeutic targets and treatment strategies. TAF9A monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of fundamental biological processes and disease mechanisms.